Previous 10 | Next 10 |
Laboratory Corporation of America (NYSE:LH) on Tuesday announced a collaboration with developer of cell and gene therapy technologies Xcell Biosciences. Labcorp and Xcell will work on a series of projects focused on improving the safety and efficacy of cell and gene therapies. The projects in...
Strategic Relationship Highlights Broad Commitment to Driving Innovative Solutions Through Cell and Gene Therapy Labcorp (NYSE: LH), a leading global life sciences company, is collaborating with Xcell Biosciences, Inc. (Xcellbio), a leading developer of cell and gene therapy...
Amid a down market, Guardant shares are trading at a bargain to their estimated value. Meanwhile, Guardant continues to procure robust sales increases and narrowed its bottom line depreciation. The recent Epic deal for its diagnostics to reach over 250M patients is a transformativ...
Medpace Holdings is a healthy business trading at a discount to its intrinsic value. Price target $193-200. The company has zero debt vs peer group average of $5.6B debt. Lower risk of permanent loss of capital vs peers. Medpace top-line in the past four years grew at 17.5% CAGR v...
Laboratory Corporation of America (NYSE:LH) declares $0.72/share quarterly dividend. Forward yield 1.09% Payable June 9; for shareholders of record May 19; ex-div May 18. See LH Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Laboratory Corporation of Am...
Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 9, 2022, to stockholders of record as of the close of business on...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
IHF is a rare healthcare ETF that outperforms S&P500 consistently. IHF’s significant holdings generated considerable price growth. Healthcare services and Managed healthcare sector stood out during the pandemic crisis, and are expected to grow further. For further...
Ariel Investments’ 13F portfolio value increased from $10.94B to $11.86B this quarter. They increased Nielsen Holdings and Core Laboratories while reducing KKR and dropping Johnson & Johnson. The top three positions are Madison Square Garden Entertainment, Mattel, and F...
Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the first quarter of 2022 before the market opens on Thursday, April 28, 2022. The company will host a conference call and webcast beginning at 9 a.m. EDT that day to discuss the results. ...
News, Short Squeeze, Breakout and More Instantly...
Laboratory Corporation of America Holdings Company Name:
LH Stock Symbol:
NYSE Market:
Labcorp to Announce Second Quarter Financial Results on August 1, 2024 PR Newswire BURLINGTON, N.C. , July 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for ...
2024-06-19 01:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials PR Newswire Suite of digital and data solutions designed to improve clinical trial efficiency, reduce data delays and simplify investigator site workflows BURLINGTON, N.C. , June 17, 2024 /PR...